Intrinsic value of Evolent Health, Inc (EVH)

[per Chepakovich valuation model]

other valuations of EVH

[per Chepakovich valuation model]  See other valuations of EVH stock

Previous Close$19.98
Intrinsic Value
Upside potential
Previous Close
$19.98

VALUATION INPUT DATA

Revenue, mln $
Initial revenue growth rate (norm.), %
Variable cost ratio, %
Fixed operating expenses, mln $
Production assets / Revenue, %
Working capital / Revenue, %
Interest rate on debt, %
Life of production assets, yrs
Initial discount rate, %
Shares outstanding, mln
Adjusted equity ratio
Adjusted assets / Revenue
Based on fiscal year data as of 2020-12-31 and quarterly data as of 2020-12-31.
NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.
  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2020(a)2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %20.8NaN
Revenue, $1022NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1293NaN
Operating income, $m-271NaN
EBITDA, $m42NaN
Interest expense (income), $mNaN
Earnings before tax, $m-338NaN
Tax expense, $m-4NaN
Net income, $m-334NaN

BALANCE SHEET

Cash and short-term investments, $m359NaN
Total assets, $m1370NaN
Adjusted assets (=assets-cash), $m1011NaN
Average production assets, $m837NaN
Working capital, $m144NaN
Total debt, $m263NaN
Total liabilities, $m751NaN
Total equity, $m620NaN
Debt-to-equity ratio0.425NaN
Adjusted equity ratio0.258NaN

CASH FLOW

Net income, $m-334NaN
Depreciation, amort., depletion, $m313NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-16NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-29NaN
Free cash flow, $m13NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m144
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN